Citi Raises Price Target for BJ ENT WATER (00371.HK) to $2.85, Anticipates Increased Cash Flow and Dividends
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 07 2026
0mins
Source: aastocks
Citi Research Rating: Citi Research has reaffirmed a Buy rating for BJ ENT WATER (00371.HK) and increased its target price from $2.65 to $2.85.
Profit Forecasts: The broker raised its net profit forecasts for 2025-2027 by 1-2% due to lower financial costs.
Free Cash Flow Expectations: The company is expected to generate approximately RMB1 billion in positive free cash flow annually, which will be allocated for dividends and debt repayment.
Dividend Growth: With improving cash recovery from accounts receivable, dividends are projected to grow by 3-5% year-over-year in 2025.
Analyst Views on 00371
Wall Street analysts forecast 00371 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00371 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 2.560
Low
Averages
High
Current: 2.560
Low
Averages
High
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
